|Articles|April 30, 2021
Analysis of Bevacizumab by SEC–MALLS
Author(s)YMC Europe GmbH
In this application note, YMC’s dedicated SEC column for antibodies, YMC-SEC MAB, has been used to develop a method for bevacizumab using MALLS detection.
Newsletter
Join the global community of analytical scientists who trust LCGC for insights on the latest techniques, trends, and expert solutions in chromatography.
Related Content
Trending on LCGC International
1
Decoding Sweet Potato Drought Resilience: Metabolomic Evidence from UPLC-MS Profiling
2
Navigating Adverse Reactions in GLP-1 Treatment
3
Toward Safer Diabetes Devices: GC–MS Detection of Allergens in Sensors, Pumps, and Infusion Sets
4
Shifting GLP-1 Receptor Agonists from Proteins to Small Molecules
5
